Adult-to-Stem Cells

An international team has created human embryonic stem cells from adult skin cells for the first time.

Written byRina Shaikh-Lesko
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, ID711Researchers have grown human embryonic stem cells (hESCs) from an adult’s skin cells, according to a paper published last week (April 17) in Cell Stem Cell. The team, led by Dong Ryul Lee of the CHA Stem Cell Institute in Korea and Robert Lanza of the biotech firm Advanced Cell Technologies (ACT), used somatic cell nuclear transfer (SCNT), a technique in which the nucleus of an female egg cell is removed and replaced with the nucleus of a donor’s cell—the same technique used to clone Dolly the sheep in 1996.

Although the technique was first used last year to create hESCs from a donor nucleus taken from an infant, the current study used skin cells from a two men—one 35 years old and the other 75 years old. “There are many diseases, whether it’s diabetes, Alzheimer’s or Parkinson’s disease, that usually increase with age,” Lanza told NPR’s Shots blog, so creating stem cells using DNA from older donors is more useful for finding medical therapies than from infants.

“Overall, I think this paper is an exciting, important, and technically convincing,” Paul Knoepfler of the University of California at Davis who studies stem cells and was not involved in this study wrote on his blog. “SCNT ES cells may give us another potential tool to help ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies